Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 193

Results For "NSE"

2558 News Found

Airtel, Apollo Hospitals, and Cisco join forces for 5G connected ambulance
Digitisation | April 28, 2022

Airtel, Apollo Hospitals, and Cisco join forces for 5G connected ambulance

When a critical patient is en-route to the hospital and every second makes a difference, the 5G Connected ambulance acts as an extension of the emergency room


Ayu Health raises US $ 27 million in series B round
Startup | April 28, 2022

Ayu Health raises US $ 27 million in series B round

The round also saw participation from US-based fund 57 Stars, a few prominent angel investors, existing investors Stellaris Venture Partners, Vertex Ventures, and Alteria Capital


Remilk to build the world's largest precision fermentation facility
Biotech | April 27, 2022

Remilk to build the world's largest precision fermentation facility

Food-tech disruptor prepares to vastly scale dairy-identical, non-animal milk protein production in a pioneering sustainable industrial park in Denmark


Takeda awarded for Supply Chain and Pharma 4 at ISPE awards
Supply Chain | April 27, 2022

Takeda awarded for Supply Chain and Pharma 4 at ISPE awards

Recognition illustrates Takeda’s patient-centricity throughout its manufacturing and supply processes


Tislelizumab plus chemo show promising results for esophageal cancer in Phase III study
Biotech | April 27, 2022

Tislelizumab plus chemo show promising results for esophageal cancer in Phase III study

Results support the development of tislelizumab in potentially synergistic combinations across Novartis advanced therapeutic platforms for the treatment of an array of solid tumours


Lonza and Integral Molecular partner on biotherapeutics
News | April 26, 2022

Lonza and Integral Molecular partner on biotherapeutics

The respective expertise of Lonza and Integral Molecular will benefit drug developers in the assessment of the risk for off-target binding and activation


DCGI grants Covaxin Emergency Use Approval for children 6-12 years
Drug Approval | April 26, 2022

DCGI grants Covaxin Emergency Use Approval for children 6-12 years

Covaxin was earlier approved for children 12-18 years of age


Shionogi’s once-a-day Covid-19 anti-viral shows rapid virus clearance
Biotech | April 25, 2022

Shionogi’s once-a-day Covid-19 anti-viral shows rapid virus clearance

A separate global Phase 3 study of S-217622 is underway aiming to recruit participants globally to support regulatory filings this year


New studies presented at ECCMIC 2022 confirm benefit of remdesivir in treating Covid-19
Biotech | April 25, 2022

New studies presented at ECCMIC 2022 confirm benefit of remdesivir in treating Covid-19

Real-world evidence from more than 850,000 hospitalized patients provides clinical insights on the use of Veklury (remdesivir) as stand of care Covid-19 treatment


Doctors at Yashoda successfully treated advanced-stage laryngeal cancer
Biotech | April 25, 2022

Doctors at Yashoda successfully treated advanced-stage laryngeal cancer

Deputy Mayor from Addis Ababa (Ethiopia) battled out a rare laryngeal cancer at Yashoda Hospitals Hyderabad